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In the present study, the role of a member of the epidermal growth factor (EGF) family, heparin-binding EGF-like growth
factor (HB-EGF), in organ development was investigated by using developing mouse submandibular gland (SMG), in which
the EGF receptor signaling and heparan sulfate chains have been implicated. HB-EGF mRNA was detected in developing
SMG by RT-PCR analysis and was expressed mainly in epithelium and weakly in mesenchyme of the embryonic SMG.
Epithelial morphogenesis was inhibited by a synthetic peptide corresponding to the heparin-binding domain of HB-EGF and
by anti-HB-EGF neutralizing antibody. An in vitro assay using an EGF receptor ligand-dependent cell line, EP170.7 cells,
llowed us to detect the growth factor activity in SMG-conditioned media, which was significantly reduced by anti-HB-EGF
ntibody. Furthermore, treatment of SMG rudiments with the hydroxamate-based metalloproteinase inhibitor OSU8-1,
hich inhibits processing of EGFR ligands including HB-EGF, markedly diminished the growth factor activity in
onditioned media and resulted in almost complete inhibition of SMG morphogenesis. The inhibitory effects on
orphogenesis were reversed, though partially, by adding the soluble form of HB-EGF. Our results provide the first evidence
hat HB-EGF is a crucial regulator of epithelial morphogenesis during organ development, highlighting the importance of
ts processing by metalloproteinases. © 2001 Academic Press
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A member of the EGF family, heparin-binding EGF-like
growth factor (HB-EGF), acts as a potent ligand for the EGF
receptor (EGFR; Higashiyama et al., 1991; Raab and Klags-
brun, 1997). Like other members of the EGF family, HB-
EGF is synthesized as a membrane-anchored protein that is
cleaved by the MMP (matrix metalloproteinase) and ADAM
(a disintegrin and metalloproteinase) families of metallo-
proteinases, giving rise to the soluble factor. Recent studies
have revealed unique roles of the HB-EGF processing by
metalloproteinases not only in signal transduction but also
1 The first two authors contributed equally to this work.
2 To whom correspondence should be addressed. Fax: 181-6-6850-5817. E-mail: yhieda@bio.sci.osaka-u.ac.jp.
202n biological processes. For instance, this processing is
nvolved in transactivation of the EGFR by G-protein-
oupled receptor signaling (Prenzel et al., 1999) and in
ound healing (Tokumaru et al., 2000). The identity of the
etalloproteinases responsible for the HB-EGF processing
n these events and in vivo, however, remains to be deter-
ined, though MMP-3 and ADAM9 (meltrin-g/MDC9) can
mediate the HB-EGF processing in in vitro culture systems
(Suzuki et al., 1997; Izumi et al., 1998). The activity of
HB-EGF as well as that of amphiregulin, another EGF
family member, is also regulated by ligand interaction with
heparan sulfate proteoglycan (HSPG), whose interaction is
inhibited by synthetic peptides spanning the heparin-
binding domain as well as by heparitinase treatment. The
ligand interaction with HSPG is required for HB-EGF to
activate the EGFR (Aviezer and Yayon, 1994) and to pro-
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203HB-EGF in Developing SMGmote migration of smooth muscle cells (Higashiyama et al.,
993) and blastocyst implantation in the uterine epithelium
Paria et al., 1999). Thus, HB-EGF plays pivotal roles in
hysiological and pathological situations. Although HB-
GF expression has been demonstrated in a variety of
issues, however, the role of the molecule in tissue mor-
hogenesis during organ development is largely unknown.
The submandibular gland (SMG) of embryonic mice has
ong been studied as a model system to understand the
echanisms of epithelial branching morphogenesis and
pithelial–mesenchymal interaction (Hieda and Nakanishi,
997). The SMG epithelium is derived from a small region
f the oral epithelium that starts to invaginate into the
andibular mesenchyme at around embryonic day 11 (E11).
t E12, the growing SMG epithelium forms a bulbous
obule at the distal region of the stalk connected to the oral
pithelium. Thereafter, the epithelium undergoes repetitive
ranching morphogenesis that is characterized by cleft
ormation on the lobular surfaces and growth of the sepa-
ated lobules.
Previous studies have clearly shown that the EGFR plays
role in epithelial morphogenesis of the mouse embryonic
MG. The EGFR is expressed in the epithelium of the
eveloping SMG (Gresik et al., 1997), and inhibition of
GFR tyrosine kinase activity by tyrphostin retards the
ranching morphogenesis (Kashimata and Gresik, 1997).
mong members of the EGF family, EGF and TGF-a have
een suggested to participate in SMG morphogenesis, serv-
ng as ligands for the EGFR. EGF or TGF-a can substitute
or mesenchyme in supporting branching morphogenesis of
MG epithelium in a clot with Matrigel (Nogawa and
akahashi, 1991; Takahashi and Nogawa, 1991) and exog-
nous EGF stimulates the EGFR to promote epithelial
orphogenesis in the developing SMG (Kashimata and
resik, 1997). A recent study by Kashimata et al. (2000) has
shown that the stimulatory effect of EGF on SMG morpho-
genesis requires the activation of ERK-1/2 signaling, one of
the intracellular signaling cascades triggered by EGFR acti-
vation.
Direct evidence has not been obtained, however, that
endogenous EGF and/or TGF-a functions in the developing
MG, though mRNAs for these molecules are expressed in
he developing SMG. Since expression levels of mRNA for
GF and TGF-a are very low at early developmental stages
f the mouse embryonic SMG (Kashimata and Gresik,
997), there is also the possibility that other EGF family
embers are involved in early SMG development. On the
ther hand, it has been shown that treatment of SMG
udiments at the early developmental stages with hepariti-
ase results in abrogation of the epithelial morphogenesis,
uggesting the involvement of heparan sulfate proteoglycan
HSPG) (Nakanishi et al., 1993; Mori et al., 1994). There-
ore, we examined in the present study the expression in the
eveloping SMG of HB-EGF and amphiregulin, which is
nother EGF family molecule that interacts with HSPG to
erve as a ligand for the EGFR. RT-PCR analysis demon- c
Copyright © 2001 by Academic Press. All righttrates predominant expression of mRNA for HB-EGF, but
ot that for amphiregulin, in the developing SMG. HB-EGF
RNA was expressed mainly in the epithelium of the
mbryonic SMG and weakly in mesenchymal cells adjacent
o the epithelium. Perturbation of HB-EGF activity resulted
n inhibition of early epithelial morphogenesis. In addition,
nhibition of epithelial morphogenesis of developing SMG
y a synthetic inhibitor of metalloproteinases was rescued,
hough only partially, by the addition of the soluble HB-
GF. These results provide evidence that HB-EGF and its
rocessing by metalloproteinases are involved in epithelial
orphogenesis during organ development.
MATERIALS AND METHODS
Materials
A 22-residue synthetic peptide, NKEEHGKRKKKGKGL-
GKKRDPC, corresponding to the heparin-binding domain of
human HB-EGF (Higashiyama et al., 1993; Thompson et al.,
994) was synthesized by use of an Applied Biosystems Pep-
ide Synthesizer. A hydroxamate-based compound, OSU8-1
[4-(N-hydroxyamino)-2R-isobutyl-3S-methylsuccinyl]-L-3-(5,6,7,8-
etra-hydro-1-naphthyl)alanine-N-methylamide} was synthesized
y Kanebo Ltd. (Osaka, Japan). The soluble form of human recom-
inant HB-EGF was produced as described (Higashiyama et al.,
991). Human recombinant TGF-a was obtained from Gibco BRL
and Strathmann Biotech. Goat anti-human HB-EGF neutralizing
antibody no. 197 was described previously (Hashimoto et al., 1994;
Horikawa et al., 1999).
Organ Culture and Growth Factor Activity
Measurements
SMG rudiments were dissected from embryos of ddY strain mice
(Nihon SLC, Hamamatsu, Japan) in Hanks’ balanced salt solution.
The day of discovery of the vaginal plug was designated as embry-
onic day 0 (E0). E12 and E13 SMG rudiments were cultured on a
Millipore filter with 199 medium containing 10% fetal calf serum
(FCS) at liquid-air interface as described (Mori et al., 1994).
For antibody inhibition experiment, recombination culture of
epithelium and mesenchyme was performed as described previ-
ously (Iwai et al., 1998). In brief, after treatment of E13 SMG
rudiments with dispase (Godo Shusei Co., Tokyo, Japan) and
careful separation of epithelium and mesenchyme, the tissue
fragments were recombined and cultured on a Millipore filter with
199 medium containing 10% FCS in the presence of antibodies.
For measurements of growth factor activity in SMG-conditioned
media, 160 of E13 SMG rudiments were dissected and each half of
the rudiments was cultured in a well of a 96-well culture plate in
100 ml of medium with or without 20 mM OSU8-1. Culture media
ere collected and changed every 24 h and the conditioned media
ollected were stored at 280°C until measurement. Growth factor
ctivity in conditioned media was monitored as reported previ-
usly (Higashiyama et al., 1995). Briefly, EP170.7 cells, which grow
ependent on EGFR ligands, were cultured in SMG-conditioned
edia for 36 h, followed by a 4-h incubation with [3H]thymidine.
he EP170.7 cells were harvested and [3H]thymidine incorporated
nto DNA was measured. For conditioned media of SMG rudiments
ultured without OSU8-1, growth factor activity was measured in
s of reproduction in any form reserved.
d
(
m
2
t
o
a
5
i
5
5
a
5
5
a
5
5
e
r
t
w
7
7
1
A
a
i
d
e
t
f
a
f
T
d
a
a
3
6
S
c
m
U
a
c
2
a
B
s
1
m
t
G
T
i
p
s
e
H
e
m
c
204 Umeda et al.the presence or absence of anti-human HB-EGF neutralizing anti-
body no. 197 (10 mg/ml).
RT-PCR
SMG rudiments were freshly prepared from E12–E15 embryos to
isolate total RNA by use of a S.N.A.P. Total RNA Isolation Kit
(Invitrogen). The quantity of RNA recovered was determined
spectrophotometrically at OD260, and the quality of the RNA was
checked by electrophoresis in agarose gels. Purified RNA was
stored at 280°C. Two micrograms of total RNA isolated from SMG
rudiments at each developmental stage were reverse transcribed to
cDNA by incubation at 42°C for 60 min with 200 U of SuperScript
II reverse transcriptase (Gibco BRL) and 500 ng oligo(dT) primer in
50 ml of 50 mM Tris–HCl (pH 8.3), 10 mM dithiothreitol, 1 mM
NTP, 75 mM KCl, 3 mM MgCl2, and 2.5 U of RNase inhibitor
Gibco BRL). The reaction was terminated by heating at 70°C for 15
in, and the mixture was then incubated with RNase H at 37°C for
0 min.
The polymerase chain reaction (PCR) was carried out by using 1
ml of cDNA obtained by reverse transcription, 0.5 mM concentra-
ion of each primer, and 0.5 U of Taq polymerase (Takara) in 20 ml
f 10 mM Tris–HCl (pH 8.3) containing 0.2 mM dNTP, 50 mM KCl,
nd 1.5 mM MgCl2. Primer pairs were as follows: HB-EGF,
59-ATGAAGCTGCTGCCGTCG-39 (positions 1–18) and
9-TCAGTGGGAGCTAGCCAC-39 (positions 610–627), generat-
ng a PCR product of 627 bp (Abraham et al., 1993); amphiregulin,
9-CGCTGCTACCGCTGGCGCGC-39 (positions 11–30) and
9-TATTCCCTGAAGTATCGTTT-39 (positions 661–680), gener-
ting a PCR product of 670 bp (Das et al., 1995); EGF,
9-TACTCAGCGTCACAGCATGG-39 (positions 68 – 87) and
9-AGCCACCCTCATAATCACAG-39 (positions 708–727), gener-
ting a PCR product of 660 bp (Gray et al., 1983); TGF-a,
9-CGACCGGACAGCTCGCTCTG-39 (positions 11–30) and
9-TGGGTGTACTGAGCGAGCCC-39 (positions 670–689), gen-
rating a PCR product of 679 bp (Berkowitz et al., 1996). The
eaction mixtures were heated at 94°C for 5 min and then subjected
o 35 cycles for amplification. Cycle parameters for amplification
ere as follows: HB-EGF, 94°C for 1 min, 55°C for 1.5 min, and
2°C for 1 min; amphiregulin, 94°C for 1 min, 58°C for 1.5 min, and
2°C for 1 min; EGF, 94°C for 1 min, 61°C for 1.5 min, and 72°C for
min; TGF-a, 94°C for 1 min, 67°C for 1.5 min, and 72°C for 1 min.
liquots of PCR products were subjected to electrophoresis in an
garose gel and visualized by staining with ethidium bromide. The
dentity of the PCR products was verified by restriction enzyme
igestion and sequencing.
In Situ Hybridization
Mouse HB-EGF cDNA obtained by RT-PCR as described above
was cloned into the pCR II vector (Invitrogen), and antisense and
sense digoxigenin (DIG)-labeled riboprobes were synthesized by
using DIG RNA labeling mix according to the manufacturer’s
instruction (Roche). Embryonic submandibular glands freshly pre-
pared for in situ hybridization were frozen in liquid nitrogen,
mbedded in OCT compounds, and kept at 280°C until hybridiza-
ion. Ten-micrometer sections were fixed in 4% paraformaldehyde
or 15 min, washed in PBS containing 0.1% active DEPC (Sigma),
nd prehybridized for 3 h at 58°C in hybridization buffer [50%
ormamide, 53 sodium saline citrate (SSC), 10 mg/ml yeast tRNA].
he riboprobes were heated at 65°C for 10 min, cooled on ice,
iluted to a concentration of 500 ng/ml in hybridization buffer, and
Copyright © 2001 by Academic Press. All rightpplied to the sections. The slides were covered with a coverslip
nd hybridized at 58°C for 40 h. They were washed in 23 SSC for
0 min at 58°C, in 23 SSC for 1 h at 65°C, in 0.13 SSC for 1 h at
5°C, and equilibrated in 100 mM maleic acid (pH 7.5) for 5 min.
ections were then incubated for 2 h with alkaline phosphatase-
onjugated goat anti-DIG antibody (Roche) diluted 1:10,000 in 100
M maleic acid (pH 7.5) with 1% blocking reagent (Roche).
nbound antibody was removed by two washes in 100 mM maleic
cid (pH 7.5) and the sections were equilibrated with buffer
ontaining 100 mM Tris–HCl, 100 mM NaCl, 50 mM MgCl2, and
mM levamisole, pH 9.5. Color development was performed in the
bove buffer containing NBT (nitro blue tetrazolium, Roche) and
CIP (5-bromo-4-chloro-3-indolyl phosphate, Roche) for 16 h. The
lides were incubated in 10 mM Tris–HCl, 1 mM EDTA, pH 8.0, for
0 min, in 95% ethanol overnight, in distilled water for 15 min, and
ounted in PBS:glycerol (1:1).
RESULTS
Expression of HB-EGF in Developing SMG
We examined the expression of mRNA for HB-EGF and
amphiregulin in the developing SMG at E12 through E15,
comparing with that for EGF and TGF-a. RT-PCR analysis
was conducted by using primer sequences specific for these
molecules (Fig. 1A). At all of the stages examined, mRNA
coding for HB-EGF was predominantly detected, whereas
mRNA for amphiregulin was only faintly detected. With
the same primer set, amphiregulin mRNA was clearly
detected in the developing lungs, which served as a positive
control (Schuger et al., 1996; data not shown). The expres-
sion of mRNA of EGF and TGF-a was low until E14 and
hereafter increased, as reported previously (Kashimata and
resik, 1997). Similar results were obtained reproducibly.
hese data indicate that HB-EGF rather than amphiregulin
s the major heparin-binding EGF family molecule ex-
ressed in the developing SMG at the early developmental
tages.
In situ hybridization was performed to determine the
xpression pattern of HB-EGF mRNA in E13 SMG (Fig. 1B).
B-EGF mRNA was expressed mainly in the epithelium,
specially in the lobular region. We also recognized that its
RNA was weakly expressed in mesenchymal cells adja-
ent to the epithelium.
Inhibition of Epithelial Morphogenesis of
Developing SMG by Abolishing HB-EGF Activity
To investigate the role of HB-EGF in the developing
SMG, we cultured E12 and E13 SMG rudiments in the
presence of a 22-residue synthetic peptide corresponding
to the heparin-binding domain of HB-EGF. Synthetic
peptides spanning the heparin-binding domain have been
shown to interfere with the interaction of HB-EGF with
HSPG, resulting in abrogation of HB-EGF activity (Hi-
gashiyama et al., 1993; Aviezer and Yayon, 1994; Thomp-
son et al., 1994; Paria et al., 1999). Treatment of E12 SMG
rudiments with 60 ng/ml of the peptide resulted in
s of reproduction in any form reserved.
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205HB-EGF in Developing SMGretardation of epithelial growth and a significant decrease in
the number of the branches (Fig. 2). Epithelial morphogen-
esis of E13 rudiments was also inhibited by treating with
150 ng/ml of the peptide, in which the epithelial branches
FIG. 1. Expression of mRNA for EGF family molecules in the d
mRNA for HB-EGF in SMG rudiments at E12–E15, whereas mRNA
for EGF and TGF-a is low until E14 and increases thereafter. PCR
arkers (far left lanes). Arrows indicate the expected sizes of PCR
p for TGF-a). (B) In situ hybridization for HB-EGF mRNA in secti
especially in the lobular region, and weakly in mesenchymal cells
FIG. 2. Inhibition of E12 SMG morphogenesis by a synthetic
peptide corresponding to the heparin-binding domain of HB-EGF.
E12 SMG rudiments cultured in the absence (A, C, E) and the
presence (B, D, F) of the peptide (60 ng/ml) are shown successively
at 0 (A, B), 24 (C, D), and 48 h (E, F). In the peptide-treated rudiment,
epithelial growth and branching morphogenesis is retarded.
Copyright © 2001 by Academic Press. All rightid not have the distinct, round lobules but tended to
ecome rod shaped (Fig. 3). Notably, the epithelial shape
as similar to that of SMG rudiments treated with hepariti-
ase (Nakanishi et al., 1993; Mori et al., 1994).
oping SMG. (A) RT-PCR analysis detected obvious expression of
amphiregulin (AR) was detected only faintly. Expression of mRNA
ucts were fractionated by size on agarose gels with 100-bp ladder
ucts (627 bp for HB-EGF, 670 bp for AR, 660 bp for EGF, and 679
E13 SMG. HB-EGF mRNA is expressed mainly in the epithelium,
cent to the epithelium.
FIG. 3. Inhibition of E13 SMG morphogenesis by a peptide corre-
sponding to the heparin-binding domain of HB-EGF. E13 SMG rudi-
ments cultured in the absence (A, C, E) or the presence (B, D, F) of the
peptide (150 ng/ml) are shown successively at 0 (A, B), 24 (C, D), and
48 h (E, F). In the peptide-treated rudiments, epithelial branching
morphogenesis is markedly inhibited and the epithelial branches doevel
for
prod
prod
on ofnot have distinct, round lobules but become rod-shaped.
s of reproduction in any form reserved.
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also demonstrated by using goat anti-human HB-EGF neu-
tralizing antibody no. 197, which has been reported to
antagonize mouse HB-EGF activity by 50% (Horikawa et
al., 1999). For this purpose, we performed tissue recombi-
nation experiments since intact SMG rudiments treated
with the anti-HB-EGF antibody exhibited normal epithelial
morphogenesis. Epithelial and mesenchymal tissues taken
from SMG rudiments were recombined and cultured in the
presence of the anti-HB-EGF antibody or normal goat IgG.
We found that epithelial morphogenesis of tissue recombi-
nants was markedly inhibited by anti-HB-EGF antibody
while it was not affected by normal goat IgG (Fig. 4).
Blocking of SMG Morphogenesis by a
Metalloproteinase Inhibitor and the Rescue
by the Soluble HB-EGF
Hydroxamate-based inhibitors of metalloproteinases
have been used to study processing of EGF family mol-
ecules including HB-EGF by metalloproteinases. Recently,
OSU8-1, one of the hydroxamate-based compounds, has
been characterized as a potent inhibitor of the processing of
HB-EGF, amphiregulin, and TGF-a (Tokumaru et al., 2000).
We utilized the compound to get insight into the role of the
metalloproteinase-mediated HB-EGF processing in SMG
FIG. 4. Inhibition of SMG morphogenesis by anti-HB-EGF neutra
udiments were recombined and cultured in medium with no antib
G–I). Antibodies were added at a concentration of 50 mg/ml. Reco
(C, F, I) of culture. In the recombinants treated with anti-HB-EGFmorphogenesis. Treatment of E12 SMG rudiments with 10 c
Copyright © 2001 by Academic Press. All rightmM OSU8-1 resulted in significant retardation of epithelial
growth and branching morphogenesis (Figs. 5D–5F). When
treated with 20 mM inhibitor, the epithelial lobule grew
little and remained round with no signs of cleft formation
and branching (Figs. 5G–5I). Removal of the inhibitor (20
mM) after a 24-h treatment rapidly restored the epithelial
growth and morphogenesis over the following 24 h (Figs.
5J–5L). Epithelial development in E13 SMG rudiments was
also severely inhibited by 20 mM OSU8-1 and recovered
after removal of the compound (Fig. 6). These results
indicate an essential role of metalloproteinase activity in
SMG morphogenesis.
To see whether the inhibitory effect of OSU8-1 on SMG
morphogenesis was, at least in part, due to the impaired
processing of HB-EGF, we treated E12 SMG rudiments with
20 mM OSU8-1 for 24 h and then further incubated them
with the soluble form of HB-EGF together with OSU8-1.
During the next 24-h incubation, after the addition of
HB-EGF at a concentration of 20 ng/ml, the formation of a
couple of sharp clefts was obviously recognized, though full
restoration of epithelial morphogenesis was not achieved
(Figs. 7D–7F). Treatment with HB-EGF alone for 48 h did
not promote SMG morphogenesis under our culture condi-
tions (data not shown). TGF-a was also tested for the
ossible ability to reverse the inhibitory effects of OSU8-1
n SMG morphogenesis, since processing of this molecule
g antibody. Epithelial and mesenchymal tissues taken from SMG
added (A–C), normal goat IgG (D–F), or goat anti-HB-EGF antibody
ants are shown successively at 0 (A, D, G), 24 (B, E, H), and 48 h
ody, epithelial morphogenesis is markedly inhibited.lizin
ody
mbinan be inhibited by OSU8-1 (Tokumaru et al., 2000). The
s of reproduction in any form reserved.
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207HB-EGF in Developing SMGaddition of the soluble TGF-a, however, did not stimulate
cleft formation in SMG rudiments treated with OSU8-1
(Figs. 7G–7I).
Release of Growth Factor Activity into SMG-
Conditioned Media: Detection of HB-EGF Activity
and Impairment by Metalloproteinase Inhibitor
We tried to detect the soluble HB-EGF produced by
developing SMG. For this purpose, growth factor activity in
conditioned media of cultured E13 SMG rudiments was
monitored by measuring the incorporation of [3H]thymi-
ine into EP170.7 cells, which grow dependent on EGFR
igands (Higashiyama et al., 1995). As shown in Table 1A,
he activity to stimulate the incorporation of [3H]thymidine
into EP170.7 cells was obviously detected in SMG-
conditioned media with a gradual increase during a 72-h
culture. The growth factor activity in conditioned media
collected after the last 24-h culture corresponded to that of
approximately 0.3 ng/ml of recombinant human HB-EGF
(Table 1B). We then found that anti-human HB-EGF anti-
body no. 197 inhibited the growth factor activity in SMG-
conditioned media by 30% or more. It may imply that at
least 60% of the growth factor activity detected in SMG-
FIG. 5. Inhibition of E12 SMG morphogenesis by the synthetic m
in the absence (A–C) or presence of 10 mM (D–F) or 20 mM (G–I) of
rudiment treated with 10 mM OSU8-1, and no sign of cleft forma
orphogenesis of the rudiment treated with 20 mM OSU8-1 for 24
J–L). SMG rudiments are shown successively at 0 (A, D, G, J), 24conditioned media is attributed to HB-EGF since the anti- u
Copyright © 2001 by Academic Press. All rightbody antagonizes mouse HB-EGF activity by 50%
(Horikawa et al., 1999).
We also examined the growth factor activity in condi-
ioned media of SMG rudiments cultured in the presence of
0 mM OSU8-1, at which concentration epithelial morpho-
genesis was almost completely blocked as described above.
It was found that the growth factor activity was decreased
to less than 20% of control (Table 1A). These data together
indicate that SMG rudiments produce the soluble form of
HB-EGF resulting from the metalloproteinase-mediated
processing.
DISCUSSION
Previous studies have shown that HB-EGF and its pro-
cessing by metalloproteinases play important roles in a
variety of biological processes such as transactivation of the
EGFR by G-protein-coupled-receptor (Prenzel et al., 1999),
roliferation, migration, and survival of cells (Higashiyama
t al., 1991, 1993, 1995; Elenius et al., 1997; Miyoshi, 1997),
lastocyst implantation (Paria et al., 1999), and wound
ealing (Tokumaru et al., 2000). In the present study, the
ole of HB-EGF in organ development was investigated by
oproteinase inhibitor OSU8-1. E12 SMG rudiments were cultured
8-1 for 48 h. Epithelial morphogenesis is markedly blocked in the
is observed at a 20 mM concentration of the inhibitor. Epithelial
apidly restored during the next 24 h upon removal of the inhibitor
, H, K), and 48 h (C, F, I, L) of culture.etall
OSU
tion
h is rsing SMG rudiments of embryonic mice as a model
s of reproduction in any form reserved.
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208 Umeda et al.system. We showed that mRNA for HB-EGF was expressed
in the developing SMG at the early developmental stages,
that perturbation of HB-EGF activity led to impairment of
epithelial morphogenesis, and that HB-EGF activity was
released into SMG-conditioned media. Moreover, we dem-
onstrated that both release of growth factor activity into
conditioned media and epithelial morphogenesis of cul-
tured SMG were almost completely abolished by treatment
with a metalloproteinase inhibitor, OSU8-1, and that the
inhibitory effects on morphogenesis were reversed, though
only partially, by adding the soluble form of HB-EGF. These
data together strongly suggest that HB-EGF and its process-
ing by metalloproteinases are involved in epithelial mor-
phogenesis of developing SMG. This is the first report, as far
as we know, demonstrating the role of HB-EGF in organ
development.
It has been reported that two members of the EGF family,
EGF and TGF-a, are expressed in the developing SMG and
that these molecules exogenously added promote epithelial
morphogenesis by stimulating the EGFR signaling (Kashi-
mata and Gresik, 1997; Kashimata et al., 2000). Moreover,
EGF or TGF-a can support branching morphogenesis of the
FIG. 6. Inhibition of E13 SMG morphogenesis by OSU8-1. E13
SMG rudiments were cultured in the absence (A–C) or presence of
20 mM OSU8-1 (D–F) for 48 h. Epithelial morphogenesis is mark-
dly blocked in the rudiment treated with OSU8-1. Epithelial
orphogenesis of the rudiment treated with 20 mM OSU8-1 for
24 h is rapidly restored during the next 24 h upon removal of the
inhibitor (G–I). SMG rudiments are shown successively at 0 (A, D,
G), 24 (B, E, H), and 48 h (C, F, I) of culture.MG epithelium denuded of mesenchyme (Nogawa and 4
Copyright © 2001 by Academic Press. All rightakahashi, 1991). These observations suggest that these
GF family molecules play roles in epithelial morphogen-
sis of the developing SMG, serving as EGFR ligands. Data
ave not been obtained, however, for the involvement of
ndogenous EGF and TGF-a in SMG morphogenesis. Our
results presented here identify HB-EGF as an endogenous
EGF family molecule that is involved in SMG morphogen-
esis. Treatment with a synthetic peptide corresponding to
the heparin-binding domain of HB-EGF resulted in inhibi-
tion of SMG morphogenesis, and the epithelial shape of the
treated rudiments was reminiscent of that of the
heparitinase-treated ones. Thus, we suggest that HB-EGF in
developing SMG functions through interaction with HSPG.
HB-EGF not only acts as a potent ligand for the EGFR but
also binds to ErbB-4, another member of the EGFR family,
to activate it (Elenius et al., 1997). Since expression of
ErbB-4, however, is hardly detectable by either RT-PCR or
immunohistochemical observation (data not shown), we
suggest that HB-EGF serves as a ligand for the EGFR, but
not for ErbB-4, in the developing SMG. This implies that at
least three EGFR ligands, namely EGF, TGF-a, and HB-
FIG. 7. Stimulation by HB-EGF of cleft formation in SMG rudi-
ments treated with OSU8-1. E12 SMG rudiments were cultured in
the presence of OSU8-1 for 24 h, and then for a further 24 h with
OSU8-1 alone (A–C), or along with HB-EGF (D–F) or TGF-a (G–I).
Growth factors were added at a concentration of 20 ng/ml. In the
rudiment treated with HB-EGF (D–F), formation of sharp clefts is
obvious (arrows in F). No clefts were detected with TGF-a. SMG
udiments are shown successively at 0 (A, D, G), 24 (B, E, H), and
8 h (C, F, I).
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209HB-EGF in Developing SMGEGF, are expressed in the developing SMG. The expression
of these three molecules seems to be developmentally
regulated during SMG morphogenesis: whereas HB-EGF
mRNA, as revealed by our RT-PCR analysis, is expressed
obviously from the early developmental stage of E12, ex-
pression levels of mRNA for EGF and TGF-a rise after
E14–E15 (Kashimata and Gresik, 1997). Also, our results
presented here indicated that at least 60% of growth factor
activity detected in SMG-conditioned media was attributed
to HB-EGF. The developing SMG may thus utilize HB-EGF
as a major EGFR ligand at early developmental stages and
EGF or TGF-a at later stages. It is of note that TGF-a could
ot rescue the inhibitory effect of a synthetic inhibitor of
etalloproteinases on SMG morphogenesis. The EGFR
igands might function in different modes of action in the
eveloping SMG.
Members of the EGF family are synthesized as
embrane-anchored proteins that are cleaved by the MMP
nd ADAM families of metalloproteinases to become the
oluble forms. Peschon et al. (1998) revealed that mice
acking ADAM17 had defects of epithelial development in
ultiple organs, with the impaired processing of several
ell surface molecules including TGF-a. The results pre-
ented here suggest that the HB-EGF processing by metal-
oproteinases also plays a role in epithelial morphogenesis
uring organ development. The hydroxamate-based com-
ound OSU8-1, which inhibits a wide spectrum of metal-
TABLE 1
A. [3H]thymidine Incorporation into EP170.7 Cells Cultured in
SMG-Conditioned Media
Treatment
Activity (cpm)
Culture period of SMG (h)
0–24 24–48 48–72
None 889 (989/789) 1270 (1220/1320) 1520 (1480/1559)
1Anti-HB-EGF 615 (650/580) 827 (799/854) 978 (930/1026)
1OSU8-1 157 (118/195) 172 (138/205) 196 (148/243)
B. [3H]Thymidine Incorporation into EP170.7 Cells Stimulated
by Recombinant Human HB-EGF
HB-EGF (ng/ml) Activity (cpm)
0 96 (89/102)
0.1 274 (259/288)
0.33 1492 (1582/1402)
1.0 6990 (6981/6399)
Note. Values (cpm) indicate the means of the data obtained from
two independent experiments (parenthesis). Growth factor activity
accumulated in SMG-conditioned media during the indicated pe-
riod of culture was measured. OSU8-1 (20 mM) was included
hroughout the culture of SMG rudiments and anti-HB-EGF (10
mg/ml) was added to conditioned media.oproteinases, almost completely blocked both release of
Copyright © 2001 by Academic Press. All rightrowth factor activity into conditioned media and epithelial
orphogenesis of SMG rudiments; the inhibitory effect of
SU8-1 on morphogenesis was reversed, though only par-
ially, by addition of the soluble HB-EGF. Although con-
rming the important role of the soluble HB-EGF released,
ur results do not exclude the possibility that the
embrane-anchored form plays a role in the developing
MG. In fact, the present study together with the previous
eport by Gresik et al. (1997) shows that both HB-EGF and
he EGFR are expressed mainly in the epithelium of the
eveloping SMG, though they are also expressed weakly in
he mesenchyme. In addition, the epithelium of the devel-
ping SMG expresses CD9 (data not shown), which together
ith integrin a3b1 has been shown to interact with and
otentiate the juxtacrine activity of membrane-anchored
B-EGF (Iwamoto et al., 1994; Higashiyama et al., 1995;
akamura et al., 1995; Miyoshi et al., 1997).
Finally, it would be reasonable to assume that, in addi-
ion to the metalloproteinase(s) responsible for the HB-EGF
rocessing, several other metalloproteinases expressed in
eveloping SMG are inhibited by the synthetic compound
SU8-1 since the compound inhibits a wide spectrum of
etalloproteinases (Tokumaru et al., 2000) and the inhibi-
ory effect of OSU8-1 on SMG morphogenesis was only
artially reversed by HB-EGF. Metalloproteinases of the
MP and ADAM families are involved not only in process-
ng of cell surface molecules including the EGFR ligands
ut also in digestion and remodeling of the extracellular
atrix molecules that allow cell migration and tumor
rogression (Black and White, 1998; Bergers and Coussens,
000). It has been demonstrated that extracellular matrix
omponents such as collagens in mesenchyme are remod-
led during SMG development (Nakanishi et al., 1986,
988; Ichikawa and Nakanishi, 1992) and that the mesen-
hymal cells in developing SMG exhibit massive, flowing
ovements (Hieda and Nakanishi, 1997; Nakanishi et al.,
n press). It is likely that metalloproteinase activity is
nvolved in the mesenchymal morphogenetic movements.
dentification of metalloproteinases expressed in the devel-
ping SMG will provide clues for uncovering the role of
etalloproteinases in both epithelial and mesenchymal and
orphogenesis and in the tissue interaction between them.
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